• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Alerts

Gynecologic Management of Patients with Seizure Disorders

image_pdfFavoriteLoadingFavorite

SUMMARY:

Seizure disorders are frequently diagnosed during adolescence and can be associated with many different conditions including epilepsy, brain infections/tumors, or traumatic brain injuries.  Seizures can increase in frequency with menarche, and both the condition itself as well as the treatments can have important effects on gynecologic health.

Epilepsy can also have effects on menses. Patients with epilepsy are more likely to have irregular menstrual bleeding, amenorrhea, or anovulatory cycles.  Therefore, gynecologists should work with patients and their families to help manage menses

Seizures Associated with Menses

  • Catamenial seizures are cyclic exacerbation of seizures that occur with the menstrual cycle
    • Catamenial epilepsy defined as a twofold increase in in baseline daily seizure activity that occurs in at a particular phase of the menstrual cycle
    • Diagnose by evaluating both menstrual and seizure diary
  • Most common increase in seizures occurs 3 days before menses and first 3 days of menses
    • Correlates with progesterone drop
    • Patients have fewest seizures during midluteal phase when progesterone is highest

Contraceptive Options

Medroxyprogesterone (DMPA) (USMEC Cat I)

  • The standard dose of DMPA has shown to decrease seizure frequency
    • Although antiepileptic medications remain first line treatment for seizures, DMPA has been studied as a as an adjuvant therapy for catamenial seizures

Levonorgestrel-containing IUD (USMEC Cat I)

  • Safe and effective method for patients who desire menstrual management and/or contraception

Note: Efficacy not affected by enzyme inducing antiepileptic drugs

Etonogestrel Implant (USMEC Cat 2)

  • Etonogestrel concentrations in serum found to be lower in patients taking certain antiepileptics
  • Likely still very effective

Norethindrone Pills (USMEC Cat 3)

  • Not recommended for contraception due to potential decreased efficacy of enzyme inducing antiepileptic drugs
  • Can be used for menstrual suppression

Combined Hormonal Contraception (USMEC Cat 1 or 3 depending on medication patient is on)

  • Patients with epilepsy have a higher contraception failure rate than those without
  • Systemic combined hormonal contraception can interact with liver enzyme inducers
    • Carbamazepine
    • Felbamate
    • Oxcarbazepine
    • Phenobarbital
    • Phenytoin
    • Primidon
    • Rufinamide
  • Recommendations for prescribing OCPs in patients using enzyme inducing antiepileptics (although not evidence based)
    • Prescribe high dose OCPs (>35 mcg)
    • Prescribe extended cycle OCPs
    • Decrease hormone free interval to <7 days to minimize risk of ovulation
    • Patient should use barrier method
  • If patient is taking lamotrigine, collaboration with a neurologist should always occur

Emergency Contraception

  • All methods of emergency contraception can be used
  • Copper IUD will provide both emergency and long-term contraception, and is rate Cat I
  • Levonorgestrel and ulipristal acetate are Cat 2 in patients using CYP3A4 inducers, but this is just a theoretical risk

Pregnancy Planning

  • If possible, all patients with a seizure disorder who desire pregnancy should have neurologist appointment to discuss medication optimization to decrease teratogenic potential
  • If patient is found to be pregnant, antiepileptic drugs should NOT be abruptly stopped

Note: Be aware of anti-epileptic drugs that induce liver enzymes and decrease efficacy of contraception 

Learn More – Primary Sources

Gynecologic Management of Adolescents and Young Women With Seizure Disorders

CDC Medical Eligibility Criteria for Contraceptive Use

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Alerts Posts
Next >

Related ObG Topics:

Data from the MONEAD Study: Do Women with Epilepsy Experience More Seizures During Pregnancy?
Expert Opinion: Over-the-Counter Contraceptives for Adolescents
ACOG & SMFM Guidance on the Use of IUDs and Contraceptive Implants

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site